About Akesis Biologics
About Akesis
Akesis Biologics is a biotech spin-off from the National University of Singapore, focused on developing science-driven solutions for gut health and disease prevention. Our flagship product, MastGut, is based on groundbreaking research published in Nature Oncogene, using gene-based probiotic delivery to support digestive health and reduce gut inflammation and suppress tumor gene expression. Akesis Biologics aims to bring advanced science into everyday wellness, bridging the gap between medical innovation and natural health.
Our Team
Prof Zhang Yongliang, (Co-founder & CEO)
Dr Chin Wen Png (Co-founder & CTO)
Fang (Co-founder & COO)
Associate Professor,SoM, NUS;
Postdoc in Immunology, Uni of Washington &MD Anderson Cancer center;
>20 years research experience in immunity & cancer
Research focuses on infection,
inflammation, cancer and development of therapeutics for disease treatment
PhD in the field of Medicine.
University of Queensland,
Australia;
>10 years research
experience in gastrointestinal
disorders including gut
inflammation & cancer
Master in Electrical Engineering, NUS ;
6 years in Sales and Business development achieving 7-figure annual sales;
3 years experience in MedTech startup with 3 million USD fundraising experience and achieved 5 million USD revenue